
CCRM solves the big challenges in cell and gene therapy through seamless integration of extensive expertise, enabling technologies, collaborative processes, and specialized infrastructure.
Our team is comprised of 150+ dedicated Scientists, Process Engineers, Operators, and Quality staff who have years of experience in the development and manufacturing of regenerative medicine technologies including iPSC-derived therapies. Located in Toronto’s MaRS Discovery District, CCRM is part of a leading-edge biomedical ecosystem with world-renowned clinical and academic facilities that are steps away.



Lise Munsie, Ph.D.
Director, Process Development and Analytical Development

Kyle Ritchie, B.Sc.
Director, Business Development
